Eiko Lifesciences Other Announcement
Eiko Lifesciences informed exchanges that it sent the AGM notice and Annual Report weblink to shareholders who have not registered email addresses.
ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
4 announcements with these filters
Eiko Lifesciences informed exchanges that it sent the AGM notice and Annual Report weblink to shareholders who have not registered email addresses.
This is a routine quarterly shareholding pattern filing for Eiko Lifesciences Ltd for the quarter ended June 30, 2026.
Eiko Lifesciences filed its Annual Secretarial Compliance Report for the year ended March 2026. The auditor confirmed general regulatory compliance with no material adverse observations.
Eiko Lifesciences Limited submitted a certificate under Regulation 74(5) of SEBI Regulations for the quarter ended March 31, 2026. The company’s Registrar, Bigshare Services Pvt. Ltd., confirmed that no dematerialization requests for equity shares were received during this period.